as on September 18, 2025 at 4:01 pm IST
Market Cap
₹583.47 Cr
Return on Equity (ROE)
8.1
PE Ratio (TTM)
10.86
Return on capital employed (ROCE)
11.75
Industry PE ratio
42.26
Beta (LTM)
0.96
P/B Ratio
0.68
Dividend Yield
0PEG Ratio
0.58
Quarterly Earnings Growth YOY
686.89
EPS (TTM)
33.9
Sector
Pharmaceuticals
Book Value
419.65
Technical Analysis
Bearish
View Technical Analysis
as on September 18, 2025 at 4:01 pm IST
Venus Remedies in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (10.86x)
September 18, 2025
Industry (42.26x)
September 18, 2025
Highest (21.70x)
December 28, 2023
Today’s Price to Earnings Ratio: 10.86x
Compare market cap, revenue, PE, and other key metrics of Venus Remedies with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 583.47 | 42.02% | 0.50 | 45 | 647 | |
NA | 17.82 | 125.68% | 0.00 | NA | NA | |
NA | 1,620.31 | -0.04% | 0.56 | 90 | 809 | |
NA | 235.45 | 157.41% | 0.00 | 2 | 386 | |
NA | 766.46 | 108.28% | 0.51 | 18 | 156 |
Search interest for Venus Remedies Ltd Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Venus Remedies.
Venus Remedies Ltd’s net profit jumped 686.89% since last year same period to ₹9.60Cr in the Q1 2025-2026. On a quarterly growth basis, Venus Remedies Ltd has generated -54.29% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2013, Venus Remedies Ltd has declared dividend of ₹3.00 per share on 20 May 2013 - translating a dividend yield of 1.36%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 1.34% to 2.24% in Jun 2025 quarter
Best in 1 Year
In the last 1 year, VENUSREM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.7% return, outperforming this stock by 44.7%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 41.76% of holdings in Jun 2025 quarter
Price Dip
In the last 1 month, VENUSREM stock has moved down by -8.8%
Retail Holding Down
Retail Investor have decreased holdings from 56.90% to 55.89% in Jun 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 201.73 Cr → 140.59 Cr (in ₹), with an average decrease of 30.3% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 21.0 Cr → 9.6 Cr (in ₹), with an average decrease of 54.3% per quarter
Organisation | Venus Remedies Ltd |
Headquarters | Panchkula |
Industry | Pharmaceuticals |
CEO | Pawan Chaudhary |
E-voting on shares | Click here to vote |
Venus Remedies share price today stands at ₹436.5 as on . Venus Remedies share today touched a day high of ₹453.4 and a low of ₹433.95.
Venus Remedies touched a 52 week high of ₹567.8 and a 52 week low of ₹270.25. Venus Remedies share price today i.e. is trending at ₹436.5, which is -23.12% down from its 52 week high and 61.52% up from its 52 week low.
Venus Remedies market capitalisation is ₹583.47 Cr as on .
To buy Venus Remedies shares, you need to follow these steps:
Venus Remedies trading volume is 29.55K as on . This means that 29.55K shares of Venus Remedies were bought and sold on the stock market during today's trading session.